Santyl market seen growing on chronic wounds, burns and higher health spending

The Business Research Company says the Santyl market is set for steady growth through 2035, driven by more chronic wounds, more burn injuries and rising healthcare spending. North America held the largest share in 2025, while Asia-Pacific is projected to grow fastest.

Why it matters: - Santyl is used in wound care to remove dead tissue and support healing, so demand tracks broader pressure from chronic wounds and burn injuries. - The market outlook points to expanding use of non-surgical and advanced wound care products as health systems look for lower-cost treatment options. - The forecast matters for wound care providers, payers and patients because more home-based and outpatient treatment can shift where care is delivered.

What happened: - The Business Research Company published its Santyl Market Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report says the Santyl market grew in the historical period on the back of chronic ulcers, diabetic foot wounds, burn injuries, outpatient wound care and better clinical understanding of enzymatic debridement. - The report forecasts growth through 2035 and points to an aging population, home-based wound management and stronger infection prevention as key drivers. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period.

The details: - Santyl is a prescription ointment that uses enzymatic action to debride wounds by removing dead tissue. - Santyl is primarily prescribed for chronic and acute skin ulcers or burn wounds. - The report highlights rising chronic wounds as a major growth driver. - Chronic wounds are wounds that do not heal within the usual 4 to 6 weeks and are often linked to diabetes, poor circulation or extended pressure. - OSF HealthCare reported in July 2023 that about 6.7 million people in the United States live with chronic wounds, with annual growth expected to exceed 2%. - The report also points to burn injuries as a second major driver. - Burn injuries can result from heat, flames, chemicals, electricity or radiation. - The International Burn Injury Database reported a 55% rise in burns and scalds among children in the first eight months of 2024 versus the same period in 2023. - Rising healthcare expenditure is another support for the market. - The UK Office for National Statistics reported a 5.6% rise in healthcare expenditure from 2022 to 2023, compared with 0.9% growth in the prior year. - The analysis covers Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, plus updated graphics and tables. - The company also published links for a free sample report and the full report: Download a free sample and View the full report.

Between the lines: - The report frames Santyl as part of a broader shift toward enzymatic and non-surgical wound care, not just a single-product market. - Its emphasis on chronic wounds, burns and home treatment suggests growth will depend on both disease burden and access to practical outpatient care. - The regional split points to a mature North American market and a faster expansion runway in Asia-Pacific.

What's next: - The market will likely be shaped by demographic aging, diabetes prevalence, burn prevention and reimbursement for advanced wound care. - The report expects continued adoption of enzymatic debridement and topical therapies as providers seek faster healing and better infection control. - The Business Research Company says its 2026 report set includes updated forecasting tools and new graphics for market planning.